Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies

Jesenak, M; Brndiarova, M; Banovcin, P; Varga, L; Farkas, H

Jesenak, M; Brndiarova, M; Banovcin, P; Varga, L; Farkas, H.

Affiliation

Jesenak, M; University Teaching Hospital. Martin. Slovakia
Brndiarova, M; University Teaching Hospital. Martin. Slovakia
Banovcin, P; University Teaching Hospital. Martin. Slovakia
Varga, L; Semmelweis University. Department of Internal Medicine. Budapest. Hungary
Farkas, H; Semmelweis University. Department of Internal Medicine. Budapest. Hungary

J. investig. allergol. clin. immunol ; 31(3): 255-256, 2021. tab

Article in English | IBECS | ID: ibc-215208

Responsible library: ES1.1

Localization: ES15.1 - BNCS

Subject(s)

Humans; Male; Aged; Angioedema/diagnosis; Angioedema/drug therapy; Autoantibodies/blood; Complement C1 Inactivator Proteins/therapeutic use; Autoantigens/blood; Autoantigens/immunology; Complement C1 Inactivator Proteins/genetics; Complement C1 Inactivator Proteins/immunology; Immunity, Humoral

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Autoantibodies / Complement C1 Inactivator Proteins / Angioedema Limits: Aged / Humans / Male Language: English Journal: J. investig. allergol. clin. immunol Year: 2021 Document type: Article Institution/Affiliation country: Semmelweis University/Hungary / University Teaching Hospital/Slovakia

Fulltext

Add to My VHL

XML

Search on Google